Literature DB >> 16965397

Expression profile of LIT1/KCNQ1OT1 and epigenetic status at the KvDMR1 in colorectal cancers.

Seiji Nakano1, Kazuhiro Murakami, Makiko Meguro, Hidenobu Soejima, Ken Higashimoto, Takeshi Urano, Hiroyuki Kugoh, Tsunehiro Mukai, Masahide Ikeguchi, Mitsuo Oshimura.   

Abstract

The human chromosome region 11p15.5 contains a number of maternally and paternally imprinted genes, and the LIT1/KCNQ1OT1 locus acts as an imprinting center in the proximal domain of 11p15.5. Loss of imprinting (LOI) of LIT1 and its correlation with methylation status at a differentially methylated region, the KvDMR1, were investigated in 69 colorectal cancer tissue specimens. LIT1 expression profiles were also examined by RNA-fluorescence in situ hybridization in 13 colorectal cancer cell lines. In 69 colorectal cancer tissue specimens, LOI of LIT1 was observed in nine of the 17 (53%) informative cases. Moreover, LOI of LIT1 was only observed in tumor samples. In the cell lines, methylation status at the KvDMR1 correlated well with LIT1 expression profiles. Loss of expression of LIT1 also correlated with enrichment of H3 lysine 9 (H3-K9) dimethylation and reduction of H3 lysine 4 (H3-K4) dimethylation. Thus, LIT1 expression appears to be controlled by epigenetic modifications at the KvDMR1, although CDKN1C expression, which is considered to be controlled by LIT1, was not associated with epigenetic status at the KvDMR1 in some colorectal cancer cell lines. Therefore, these findings suggest that LOI of LIT1 via epigenetic disruption plays an important role in colorectal carcinogenesis, but it is not necessarily associated with CDKN1C expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965397     DOI: 10.1111/j.1349-7006.2006.00305.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  39 in total

1.  Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer.

Authors:  Lei Nie; Hsing-Ju Wu; Jung-Mao Hsu; Shih-Shin Chang; Adam M Labaff; Chia-Wei Li; Yan Wang; Jennifer L Hsu; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2012-04-08       Impact factor: 4.060

Review 2.  Long non-coding RNA in health and disease.

Authors:  Philipp G Maass; Friedrich C Luft; Sylvia Bähring
Journal:  J Mol Med (Berl)       Date:  2014-02-16       Impact factor: 4.599

Review 3.  Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma.

Authors:  Mansi A Parasramka; Sayantan Maji; Akiko Matsuda; Irene K Yan; Tushar Patel
Journal:  Pharmacol Ther       Date:  2016-03-22       Impact factor: 12.310

4.  DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesions.

Authors:  Ayodele Gomih; Jennifer S Smith; Kari E North; Michael G Hudgens; Wendy R Brewster; Zhiqing Huang; David Skaar; Fidel Valea; Rex C Bentley; Adriana C Vidal; Rachel L Maguire; Randy L Jirtle; Susan K Murphy; Cathrine Hoyo
Journal:  Int J Cancer       Date:  2018-03-30       Impact factor: 7.396

Review 5.  Long Noncoding RNA and Cancer: A New Paradigm.

Authors:  Arunoday Bhan; Milad Soleimani; Subhrangsu S Mandal
Journal:  Cancer Res       Date:  2017-07-12       Impact factor: 12.701

6.  LncRNA, a novel target biomolecule, is involved in the progression of colorectal cancer.

Authors:  Weihong Sun; Shaoshao Ren; Ran Li; Qingshan Zhang; Haiping Song
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

Review 7.  Environmental Influences on Genomic Imprinting.

Authors:  Maya Kappil; Luca Lambertini; Jia Chen
Journal:  Curr Environ Health Rep       Date:  2015-06

8.  Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer.

Authors:  Mark B Leick; Christopher J Shoff; Erwin C Wang; Jaclyn L Congress; G Ian Gallicano
Journal:  Am J Stem Cells       Date:  2011-08-19

9.  Suggestive evidence for chromosomal localization of non-coding RNA from imprinted LIT1.

Authors:  Kazuhiro Murakami; Mitsuo Oshimura; Hiroyuki Kugoh
Journal:  J Hum Genet       Date:  2007-10-05       Impact factor: 3.172

10.  Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of lymph node metastasis and gastric corpus cancer.

Authors:  Yang Lu; Ping Lu; Zhi Zhu; Huimian Xu; Xike Zhu
Journal:  J Exp Clin Cancer Res       Date:  2009-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.